Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Overview

Nanjing Hicin Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry based in Nanjing, China. Since its inception in 2003, the company has been dedicated to the research, development, manufacture, marketing, and sale of pharmaceuticals, pharmaceutical preparations, and synthetic chemicals predominantly within the Chinese market. Leveraging its expertise in pharmaceuticals, it extends its offerings to technical transferring services, alongside supply chain management solutions. The company’s robust product portfolio caters to a wide range of therapeutic areas and has garnered a reputation for excellence in the industry. Furthermore, Nanjing Hicin Pharmaceutical Co., Ltd. has expanded its reach beyond domestic borders, exporting Active Pharmaceutical Ingredients (APIs) and a selection of pharmaceutical products to countries across South Asia, South America, and Europe, marking its presence on the global stage.

Products and Services

Nanjing Hicin Pharmaceutical Co., Ltd.’s diverse array of products and services is designed to meet the comprehensive needs of the healthcare sector:

• Antivirals: The company develops and manufactures advanced antiviral medications to combat various viral infections, underscoring its commitment to addressing global health challenges.
• Antibiotics: A range of antibiotic drugs forms a crucial part of its product lineup, aimed at fighting bacterial infections and preventing the spread of antibacterial resistance.
• Endocrine Drugs: Specialty drugs focusing on the treatment of endocrine disorders are developed, catering to a segment of the healthcare market that requires ongoing and focused innovation.
• Gastrointestinal Drugs: These drugs are formulated to address disorders and diseases affecting the gastrointestinal tract, offering relief and treatment options for patients suffering from such conditions.
• Orthopedic Drugs: Targeting the needs of patients with bone and joint disorders, these pharmaceuticals contribute significantly to improving the quality of life for individuals dealing with orthopedic conditions.
• Drugs for Cardio-Cerebral System: Cardiovascular and cerebrovascular diseases being leading causes of morbidity and mortality worldwide, the company’s related drug offerings aim to address these critical health areas.
• Immuno-modulate Agents: This segment includes drugs designed to modulate the immune system, either by enhancing or suppressing it, to treat a variety of diseases, including autoimmune disorders.
• Technical Transferring Services: Beyond product manufacturing, Nanjing Hicin offers its expertise through technical transferring services, facilitating knowledge and technology transfer within the pharmaceutical industry.
• Supply Chain Management Services: Recognizing the importance of an efficient supply chain in the pharmaceutical sector, the company provides comprehensive supply chain management solutions to ensure timely delivery and distribution of pharmaceutical products.
• Exportation of APIs and Formulated Products: Including omeprazole sodium and cefepime hydrochloride for injection, as well as lansoprazole tablets, the company caters to an international market, exporting to South Asian, South American, and European countries.